More structural improvementssuch as tendon integrity and joint stabilitytypically develop over 8-16 weeks
Standard TB-500 protocol: Loading phase (Weeks 1-4): 5mg twice weekly (Monday/Thursday) Total per week: 10mg Total for loading: 40mg (8 vials of 5mg) Maintenance phase (Weeks 5-12): 2-5mg once weekly Total per week: 2-5mg Total for maintenance: 16-40mg (3-8 vials) Example: 5mg vial + 2ml water = 2,500mcg/ml 5mg dose (5,000mcg) = draw 2.0ml (full vial) 2.5mg dose = draw 1.0ml TB-500 doses are MUCH larger than BPC-157
Because angiogenesis is a defining hallmark of tumor growth and metastatic progression, any therapeutic agent that enhances neovascularization could, in theory, facilitate tumor expansion and promote metastatic dissemination
Anti-inflammatory effects: Downregulates pro-inflammatory cytokines (IL-6, TNF-, IL-1) and reduces oxidative stress Gut barrier integrity: Promotes repair of tight junctions, limiting leaky gut and preventing translocation of inflammatory molecules Angiogenesis and collagen production: Enhances growth of new blood vessels and collagen fibers, accelerating tissue repair after injury or chronic inflammation How BPC-157 decreases inflammation 3 Suppresses pro-inflammatory pathways: Inhibits NF-B signaling, reducing the cascade of inflammatory cytokines Enhances anti-inflammatory factors: Upregulates protective growth factors such as VEGF (vascular endothelial growth factor) and TGF- Reduces oxidative stress: Neutralizes reactive oxygen species (ROS), decreasing tissue damage in the inflamed oral mucosa or stomach lining Restores tissue balance: Unlike broad anti-inflammatories (NSAIDs), BPC-157 doesnt shut down inflammation entirely
